相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib
Christele Desbois-Mouthon et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer
Bin-Bing S. Zhou et al.
CANCER CELL (2006)
Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma:: A novel functional target for gefitinib
M Matsuo et al.
CANCER SCIENCE (2006)
Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells
H Uemura et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach
A Lautrette et al.
NATURE MEDICINE (2005)
Secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions
A Mazzocca et al.
CANCER RESEARCH (2005)
Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression
H Yoshiji et al.
JOURNAL OF HEPATOLOGY (2005)
Liver fibrosis
R Bataller et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
ADAM17 mRNA expression and pathological features of hepatocellular carcinoma
Xiang Ding et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
S Yokohama et al.
HEPATOLOGY (2004)
Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma - Possible role of vascular endothelial growth factor
H Yoshiji et al.
TUMOR BIOLOGY (2002)
Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats
H Yoshiji et al.
JOURNAL OF HEPATOLOGY (2002)
Angiotensin II stimulates migration of retinal microvascular pericytes:: involvement of TGF-β and PDGF-BB
JA Nadal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 8377 breast cancer patients
MP Look et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
M Asakura et al.
NATURE MEDICINE (2002)
Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist
Y Fujimoto et al.
FEBS LETTERS (2001)
Angiotensin II and the heart - On the intracrine renin-angiotensin system
WC De Mello et al.
HYPERTENSION (2000)
分享论文
